MRC cleared of financial blunders

Government rejects claims that MRC mismanaged funds, but MPs won't let matter lie

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The UK government has rejected claims that the Medical Research Council (MRC) is guilty of financial bungling by misjudging its projected income and then having to turn down applications for research grants.

The Department of Trade and Industry (DTI) cleared the UK's leading medical research institution of mismanagement in its official response to a damning report from the House of Commons Science and Technology Committee. The response was delivered Wednesday, June 4, in the House of Commons and prompted an angry response from some MPs.

Although the DTI agreed the MRC needed to improve the way it makes financial judgements and "plan its forward expenditure in detail," it rejected allegations that this amounted to mismanagement.

In a detailed response to the committee's criticisms it stated, "We cannot agree with the committee's assertion that the MRC has mismanaged its funds. We are satisfied it has properly controlled its expenditure. Its accounts ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Pat Hagan

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development